Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

RheumPAC: A Wise Investment to Let Your Voice Be Heard in Washington, D.C.

From the College  |  April 5, 2021

ACR/ARP members share why they support the ACR’s nonpartisan political action committee and see it as an investment in the future of rheumatology.

Filed under:Legislation & Advocacy Tagged with:AdvocacyRheumPAC

Channel Policy Frustrations into Advocacy to Improve Patient Care

Leslie Mertz, PhD  |  April 2, 2021

Frustrated with policies he viewed as obstacles to optimal patient care, Howard Yang, MD, RhMSUS, tried advocacy as a way to turn those feelings into positive action—an eye-opening and rewarding experience he strongly recommends.

Filed under:Uncategorized Tagged with:AdvocacyGovernment Affairs Committee (GAC)Howard Yang

Total Knee Replacement Cost-Effective, Even with Obesity & Comorbidities

Lisa Rapaport  |  March 29, 2021

(Reuters Health)—Total knee replacement surgery can be a cost-effective procedure for patients with severe obesity and osteoarthritis (OA), even when they also have comorbidities such as cardiovascular disease or type 2 diabetes, a new study suggests. Researchers did a cost-benefit analysis for two patient populations (over 65 years, and age 50 to 65) who had…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:comorbiditiescostsObesityOsteoarthritistotal knee replacement

When Switching Patients to Biosimilars, Communication & Expert Nurses Reduce the Nocebo Effect

Lara C. Pullen, PhD  |  March 22, 2021

In a recent study, researchers designed an intervention centered on communication and led by nurses to address discontinuation rates among patients who had switched to a biosimilar. The nurses’ insight and experience reduced the nocebo effect during the intervention, which had an 84% retention rate for patients taking a biosimilar after one year.

Filed under:Biologics/DMARDsDrug Updates Tagged with:Biologics & Biosimilarsinfliximabinfliximab-abdanon-medical switchingRenflexis (infliximab-abda)

Safe Step Act of 2021 Aims to Put Patients First

From the College  |  March 5, 2021

Introduced in the Senate on Feb. 25, the bill would amend the Employee Retirement Income Security Act to provide a clear process and circumstances for requesting medical exceptions to step therapy protocols.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:LegislationSafe Step Actstep therapy

Reporting & Other Tips for the CARES Act Provider Relief Fund

Steven M. Harris, Esq.  |  February 16, 2021

Between April and December 2020, many eligible healthcare providers received or applied for payments from the $175 billion Coronavirus Aid, Relief and Economic Security (CARES) Act Provider Relief Fund (PRF) through the U.S. Department of Health & Human Services (HHS). On Dec.27, 2020, the Consolidated Appropriations Act, 2021 (the Appropriations Act) was signed into law,…

Filed under:Legal UpdatesPractice Support Tagged with:CARES ActCOVID-19reporting

The ACR’s 2020 Advocacy Year in Review

Blair Solow, MD, & Zachary Wallace, MD, MSc  |  February 16, 2021

To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

Filed under:From the CollegeLegislation & Advocacy Tagged with:Centers for Medicare & Medicaid Services (CMS)RheumPACstep therapytelehealthU.S. Congress

The ARP Revises Its Fundamentals of Rheumatology Course

Hiral Master, PT, PhD, MPH, Teresa J. Brady, PhD, Aileen Ledingham, PT, MS, PhD, & Carole Dodge, OT, CHT, on behalf of the ARP eLearning Subcommittee  |  February 16, 2021

The ARP’s revised Fundamentals of Rheumatology Course (FRC) will soon be released on the ACR website. The course was revamped by interdisciplinary rheuma­tology professionals emphasizing an inter-professional approach to patient care. It is intended to reach a broad audience, including nurses, occupational therapists, pharmacists, physical therapists, psychologists and social workers to name a few. However,…

Filed under:Education & Training Tagged with:Association of Rheumatology Professionals (ARP)

Advancing the ACR’s Legislative Priorities in 2021

Zach Wallace, MD, MSc  |  January 11, 2021

With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

Filed under:Legislation & Advocacy Tagged with:legislation and advocacyRheumPACZachary Wallace

ACR Advocacy: 2020 Year in Review

Blair Solow, MD  |  January 11, 2021

As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)legislation and advocacy

  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 116
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences